Search Results

Features | September 2020

Atopic Dermatitis: A Review of Common Comorbidities

It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.

Rima I. Ghamrawi, BS; Neda Ghiam, MD, MHSc; and Jashin J. Wu, MD, FAAD

Features | August 2020

Colloidal Oatmeal in the Treatment of Atopic Dermatitis

Is this plant-based intervention an effective treatment alternative?

Vipawee S. Chat, BS; Shelley K. Uppal, BS; Donovan G. Kearns, BS; and Jashin J. Wu, MD, FAAD

Features | July 2020

Management of Atopic Dermatitis During the COVID-19 Pandemic

There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.

Shelley K. Uppal, BS; Donovan G. Kearns, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

Features | July 2020

Investigational Oral Treatments for Psoriasis: A Review of Phase 2 and 3 Trials

Although biologic medications have proven to be highly effective in the treatment of psoriasis, there remains a need for oral medications that offer similar success rates. Here’s a look in the pipeline.

Donovan G. Kearns, BS; Shelley K. Uppal, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

Features | April 2020

Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review

A number of drugs in development show promise for one of the most challening skin diseases.

Donovan G. Kearns, BS; Shelley K. Uppal, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

Features | March 2020

Financial Literacy of Dermatology Residents: The Need for a Curriculum

Education on financial matters is sorely lacking in medical training.

Neda Ghiam, MD, MHSc, and Jashin J. Wu, MD, FAAD

News | March 2020

Recent Developments

Features | February 2020

Psoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter

A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.

Neda Ghiam, MD, MHSc; Rima I. Ghamrawi, BS; and Jashin J. Wu, MD, FAAD

Features | February 2020

Newly Approved Therapies for the Treatment of Plaque Psoriasis in Adults

Here’s a closer a look at recently approved agents.

Shelley K. Uppal, BS; Donovan G. Kearns, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

July 2018

Inflammatory Responses: Managing Psoriasis in Light of Comorbidities

The accumulated evidence suggests that dermatologists must take an active role in addressing risks.

Paul Winnington, Editorial Director

Clinical Focus | August 2016

Update On the Use of Spironolactone to Treat Adult Female Acne

There is a role for spironolactone in some adult female acne patients.

Joshua Zeichner, MD

July 2016

Biosimilars: What's Coming for Labeling?

The public comment period on draft labeling guidance will end next month.

Paul Winnington, Editorial Director